The Efficacy and Safety of Intermittent Low-Dose Urokinase Thrombolysis for the Treatment of Senile Acute Intermediate-High-Risk Pulmonary Embolism: A Pilot Trial.

Clin Appl Thromb Hemost · 2018 · PMC6714758 · PMID 29552916

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In addition, in the rt-PA group, the incidence of adverse events of bleeding (20.8%) trended higher than in the UK group (8.33%), but this difference did not reach statistical significance, possibly because of the small sample size.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.